BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32123067)

  • 1. Investigations of the underlying mechanisms of HIF-1α and CITED2 binding to TAZ1.
    Chu WT; Chu X; Wang J
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5595-5603. PubMed ID: 32123067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Backbone Dynamics in Modulating the Interactions of Disordered Ligands with the TAZ1 Domain of the CREB-Binding Protein.
    Berlow RB; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2019 Mar; 58(10):1354-1362. PubMed ID: 30775911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitive termination of the hypoxic response by a disordered protein switch.
    Berlow RB; Dyson HJ; Wright PE
    Nature; 2017 Mar; 543(7645):447-451. PubMed ID: 28273070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites.
    De Guzman RN; Martinez-Yamout MA; Dyson HJ; Wright PE
    J Biol Chem; 2004 Jan; 279(4):3042-9. PubMed ID: 14594809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalency enables unidirectional switch-like competition between intrinsically disordered proteins.
    Berlow RB; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrostatic Forces Control the Negative Allosteric Regulation in a Disordered Protein Switch.
    Wang Y; Brooks Iii CL
    J Phys Chem Lett; 2020 Feb; 11(3):864-868. PubMed ID: 31940206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive binding of HIF-1α and CITED2 to the TAZ1 domain of CBP from molecular simulations.
    Ruiz-Ortiz I; De Sancho D
    Phys Chem Chem Phys; 2020 Apr; 22(15):8118-8127. PubMed ID: 32242581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of allostery in a facilitated dissociation process.
    Appling FD; Berlow RB; Stanfield RL; Dyson HJ; Wright PE
    Structure; 2021 Dec; 29(12):1327-1338.e5. PubMed ID: 34520739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transition state structure for binding between TAZ1 of CBP and the disordered Hif-1α CAD.
    Lindström I; Andersson E; Dogan J
    Sci Rep; 2018 May; 8(1):7872. PubMed ID: 29777197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsically Disordered Transactivation Domains Bind to TAZ1 Domain of CBP via Diverse Mechanisms.
    Gao M; Yang J; Liu S; Su Z; Huang Y
    Biophys J; 2019 Oct; 117(7):1301-1310. PubMed ID: 31521329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the dynamics and the conformational entropy in the binding between TAZ1 and CTAD-HIF-1α.
    Nyqvist I; Dogan J
    Sci Rep; 2019 Nov; 9(1):16557. PubMed ID: 31719609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An allosteric peptide inhibitor of HIF-1α regulates hypoxia-induced retinal neovascularization.
    Usui-Ouchi A; Aguilar E; Murinello S; Prins M; Gantner ML; Wright PE; Berlow RB; Friedlander M
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28297-28306. PubMed ID: 33106407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.
    Freedman SJ; Sun ZY; Kung AL; France DS; Wagner G; Eck MJ
    Nat Struct Biol; 2003 Jul; 10(7):504-12. PubMed ID: 12778114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
    Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
    Yoon H; Lim JH; Cho CH; Huang LE; Park JW
    Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXL5 modulates HIF-1α transcriptional activity by degradation of CITED2.
    Machado-Oliveira G; Guerreiro E; Matias AC; Facucho-Oliveira J; Pacheco-Leyva I; Bragança J
    Arch Biochem Biophys; 2015 Jun; 576():61-72. PubMed ID: 25956243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
    Dyson HJ; Wright PE
    J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition.
    Shin DH; Li SH; Chun YS; Huang LE; Kim MS; Park JW
    Oncogene; 2008 Mar; 27(13):1939-44. PubMed ID: 17906695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response.
    Dames SA; Martinez-Yamout M; De Guzman RN; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5271-6. PubMed ID: 11959977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation.
    Yin Z; Haynie J; Yang X; Han B; Kiatchoosakun S; Restivo J; Yuan S; Prabhakar NR; Herrup K; Conlon RA; Hoit BD; Watanabe M; Yang YC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10488-93. PubMed ID: 12149478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.